May 9, 2014

Working-age adults with disabilities who do not get any aerobic physical activity are 50% more likely than their active peers to have a chronic disease — such as cancer, diabetes, stroke or heart disease — according to a Vital Signs report released earlier this week by the Centers for Disease Control and Prevention.

May 9, 2014

The Food and Drug Administration on Thursday approved Zontivity (vorapaxar) tablets, an anti-platelet agent that's designed to decrease the tendency of platelets to clump together to form a blood clot.

March 21, 2014

New guidelines for using statins to treat high cholesterol and prevent cardiovascular disease are projected to result in 12.8 million more U.S. adults taking the drugs, according to a research team led by Duke Medicine scientists.

February 26, 2014

New research published in the March issue of the American Journal of Medicine suggests that there is an association between a difference in interarm systolic blood pressure and a significant increased risk for future cardiovascular events, leading researchers to recommend expanded clinical use of interarm blood-pressure measurement.

February 26, 2014

Medication to treat high blood pressure in older patients appears to be associated with an increased risk for serious injury from falling, such as a hip fracture or head injury, especially in older patients who have been injured in previous falls, the JAMA Network Journals reported Monday.

January 13, 2014

New research conducted by CVS Caremark and Brigham and Women's Hospital confirms that optimal adherence to medications prescribed after a heart attack reduces hospital readmissions.

January 8, 2014

Japanese drug maker Daiichi Sankyo is seeking Food and Drug Administration approval for a once-daily tablet to reduce the risk of stroke in patients with atrial fibrillation and treatment of other conditions.

August 15, 2013

Boehringer Ingelheim, a research-based, global pharmaceutical company, today announced a multi-year agreement with Brigham and Women's Hospital on a long-term study program to assess comparative effectiveness and safety, as well as prescribing patterns, of oral anticoagulants, including Pradaxa, for the reduction of stroke risk in U.S. patients with non-valvular atrial fibrillation.

June 12, 2013

More than 200 drugs are under development for cardiovascular disease, according to a drug industry trade group.

June 6, 2013

Recent data suggests that aspirin may be effective for reducing cancer deaths in addition to preventing heart attacks, raising the question whether the combined health benefits outweigh the risks of gastrointestinal bleeding and stroke for middle-aged men, researchers announced Wednesday.

January 29, 2013

"Talk to your cardiologist." That's the advice offered last week by Wills Eye Institute, a hospital specializing in eye care, following a JAMA article linking aspirin therapy to macular degeneration.

January 2, 2013

The Food and Drug Administration last week approved the anti-clotting drug Eliquis (apixaban), an oral tablet used to reduce the risk of stroke and dangerous blood clots in patients with atrial fibrillation that is not caused by a heart valve problem. Eliquis is manufactured by Bristol-Myers Squibb, and marketed by BMS and Pfizer.

December 27, 2012

Researchers at the University of Gothenburg along with the Chalmers University of Technology earlier this month demonstrated that an altered gut microbiota in humans is associated with symptomatic atherosclerosis and stroke.

September 10, 2012

Some of the most commonly cited health problems affecting the elderly are hypertension, stroke and osteoporosis, but a new study highlights what researchers call an even bigger problem.

September 5, 2012

The National Community Pharmacists Association on Wednesday announced that it is participating in the "Team Up. Pressure Down." program to help hypertensive patients more effectively manage and control their high blood pressure — and ultimately prevent 1 million heart attacks and strokes by 2017.

July 31, 2012

CVS Caremark’s MinuteClinic has teamed up with the American Heart Association in a nationwide effort to improve the identification, treatment and management of high blood pressure.

July 9, 2012

The Food and Drug Administration has given priority review to a drug as a treatment for blood-clot disorders, the manufacturer said Monday.

June 21, 2012

RxAlly has created a new campaign that is designed to support the Million Hearts initiative.

May 24, 2012

A Food and Drug Administration expert panel has recommended against expanding the approval of a Johnson & Johnson drug, the company said.

May 3, 2012

Drug maker Johnson & Johnson is seeking approval from the Food and Drug Administration for a drug to treat patients with deep vein thrombosis or pulmonary embolism, the company said.

February 7, 2012

A drug under development by Merck "significantly" reduced the risk of heart attack, stroke and cardiovascular death in patients, according to clinical trial results announced Tuesday.

January 20, 2012

People who suffer from sleep disturbances are at major risk for obesity, diabetes and coronary artery disease, according to new research from the Perelman School of Medicine at the University of Pennsylvania.

December 20, 2011

A hike in blood pressure during middle age significantly raises the risk of having a heart attack or a stroke, according to new Northwestern Medicine research released Monday.

November 29, 2011

A drug designed to prevent stroke and systemic embolism in patients with atrial fibrillation has been accepted for review by the Food and Drug Administration.